Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
British Journal of Haematology
|
April 23, 2013
B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases
Anamarija M Perry, David Crockett, Bhavana J Dave, et al.
Haematologica
|
January 12, 2023
Low T-cell proportion in the tumor microenvironment is associated with immune escape and poor survival in diffuse large B-cell lymphoma
Joo Y Song, Mary Nwangwu, Ting-Fang He, et al.
Blood
|
September 7, 2013
Indolent T-cell lymphoproliferative disease of the gastrointestinal tract
Anamarija M Perry, Roger A Warnke, Qinglong Hu, et al.
British Journal of Haematology
|
November 17, 2024
Somatic co-alteration signatures are prognostic in high-grade TP53-mutated myeloid neoplasms
Emily O Symes, Peng Wang, Payal Sojitra, et al.
Hematological Oncology
|
October 21, 2015
Non-Hodgkin lymphoma in Romania: a single-centre experience
Bogdan Fetica, Patriciu Achimas-Cadariu, Bogdan Pop, et al.
Leukemia & Lymphoma
|
April 2, 2015
Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome
Gabriel C Caponetti, Bhavana J Dave, Anamarija M Perry, et al.
British Journal of Haematology
|
February 11, 2014
MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab
Anamarija M Perry, Yuridia Alvarado-Bernal, Javier A Laurini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2021
Double-hit Signature with <i>TP53</i> Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP
Joo Y Song, Anamarija M Perry, Alex F Herrera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2025
Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826
Sarah C Rutherford, Hongli Li, Alex F Herrera, et al.
Human Pathology
|
August 6, 2014
BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma
Samantha L Kendrick, Lucas Redd, Andrea Muranyi, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
British Journal of Haematology
|
April 23, 2013
B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases
Anamarija M Perry, David Crockett, Bhavana J Dave, et al.
Haematologica
|
January 12, 2023
Low T-cell proportion in the tumor microenvironment is associated with immune escape and poor survival in diffuse large B-cell lymphoma
Joo Y Song, Mary Nwangwu, Ting-Fang He, et al.
Blood
|
September 7, 2013
Indolent T-cell lymphoproliferative disease of the gastrointestinal tract
Anamarija M Perry, Roger A Warnke, Qinglong Hu, et al.
British Journal of Haematology
|
November 17, 2024
Somatic co-alteration signatures are prognostic in high-grade TP53-mutated myeloid neoplasms
Emily O Symes, Peng Wang, Payal Sojitra, et al.
Hematological Oncology
|
October 21, 2015
Non-Hodgkin lymphoma in Romania: a single-centre experience
Bogdan Fetica, Patriciu Achimas-Cadariu, Bogdan Pop, et al.
Leukemia & Lymphoma
|
April 2, 2015
Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome
Gabriel C Caponetti, Bhavana J Dave, Anamarija M Perry, et al.
British Journal of Haematology
|
February 11, 2014
MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab
Anamarija M Perry, Yuridia Alvarado-Bernal, Javier A Laurini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2021
Double-hit Signature with <i>TP53</i> Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP
Joo Y Song, Anamarija M Perry, Alex F Herrera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2025
Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826
Sarah C Rutherford, Hongli Li, Alex F Herrera, et al.
Human Pathology
|
August 6, 2014
BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma
Samantha L Kendrick, Lucas Redd, Andrea Muranyi, et al.
Page
of 6